Literature DB >> 2294704

Evaluation of the Sysmex R-1000. An automated reticulocyte analyzer.

A Tichelli1, A Gratwohl, A Driessen, S Mathys, E Pfefferkorn, A Regenass, P Schumacher, C Stebler, M Wernli, C Nissen.   

Abstract

The new fully automated reticulocyte analyzer, Sysmex R-1000 (TOA Medical Electronics, Kobe, Japan), was evaluated for its routine use in the Hematological Laboratory at the University Hospital Basel, Switzerland. The operating characteristics, such as within-run precision, linearity, and carryover, fulfilled the manufacturer's specifications and are excellent. Correlation with the standard method, manual reticulocyte counting, is linear for normal and high values. For low reticulocyte counts the regression points show a deviation from their linearity. An absolute zero value is not obtained by the R-1000. The R-1000 measures total RNA content of each cell and expresses the value as low fluorescence ratio (LFR), medium fluorescence ratio (MFR), and high fluorescence ratio (HFR). The analysis of this ratio resolves the problem of zero reticulocytes: A fraction of less than 0.002 (0.2%) with an LFR of 100% represents aplasia; a shift of the intensity of fluorescence to HFR heralds regeneration. Results of samples stored at room temperature remain stable and within the range of the within-run precision for up to 12 hours, when stored at 5 degrees C for more than 48 hours. The authors conclude that the R-1000 is easy to operate, fulfills the criteria for accuracy and precision, and is highly suitable for daily routine use in a large central hematologic laboratory.

Entities:  

Mesh:

Year:  1990        PMID: 2294704     DOI: 10.1093/ajcp/93.1.70

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

Review 1.  Reticulocytes and reticulocyte enumeration.

Authors:  R S Riley; J M Ben-Ezra; R Goel; A Tidwell
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Characterization of the myelotoxicity of chloramphenicol succinate in the B6C3F1 mouse.

Authors:  John A Turton; Rajni Fagg; William R Sones; Thomas C Williams; C Michael Andrews
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

3.  Reticulocyte counting in thalassemic and other conditions with the R-1000 Sysmex analyzer.

Authors:  G S Paterakis; E Voskaridou; A Loutradi; J Rombos; D Loukopoulos
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

4.  Reticulocyte maturity as an indicator for estimating qualitative abnormality of erythropoiesis.

Authors:  K Watanabe; Y Kawai; K Takeuchi; N Shimizu; H Iri; Y Ikeda; B Houwen
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

5.  Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease.

Authors:  Emily Riehm Meier; Elizabeth C Wright; Jeffery L Miller
Journal:  Am J Hematol       Date:  2014-06-19       Impact factor: 10.047

6.  Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease.

Authors:  Elisa Piva
Journal:  Rev Bras Hematol Hemoter       Date:  2015-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.